SubsidieMeestersMobile Bio-Lab to support first response in Arbovirus outbreaks
MOBVEC aims to develop the first VBD Mobile Bio-Lab to provide real-time vector surveillance and disease modeling, enhancing outbreak response and saving lives and healthcare costs.
Projectdetails
Introduction
The WHO estimates that vector-borne diseases (VBD) account for more than 17% of all infectious diseases. Every year, more than 2.5 billion people are at risk of contracting dengue alone, and VBDs cause almost 1 million deaths.
Background
In the last decades, several species of invasive disease-carrying mosquitoes have invaded the northern hemisphere of the planet through the transport of goods, increasing international travel, and climate change. In 2018, a West Nile fever outbreak transmitted by mosquitoes occurred in the EU. For this disease, there are no vaccines or medications. There were 1503 cases reported in 11 countries, and 181 deaths.
Need for Mobile Bio-Labs
VBD Mobile Bio-Labs could have assisted health authorities in containing this outbreak, reducing cases and preventing deaths. Unfortunately, such a system does not exist.
Project Overview: MOBVEC
MOBVEC will be the first VBD Mobile Bio-Lab, providing:
- Automatic information about vector populations, obtained in real-time by smart traps, powered by machine learning and edge computing: insect species, sex, age, and viral infection.
- GEOSS compliant vector risk maps of adult insects and eggs/larvae, built on field and Copernicus data.
- GEOSS compliant disease transmission models in mosquito populations, fusing data from Copernicus, clinical and diagnostic data of reference labs, and vector risk maps.
- GEOSS compliant citizen-science platform to reinforce the surveillance of mosquitoes using citizens as observation nodes.
- VBD mobile bio-lab with the capacities of points 1, 2, 3, and 4, plus VBD epidemiological maps and forecast models, to be rapidly operational in the heart of outbreaks to assist first responders.
Impact
This technology will be the first line of defense against disease vectors worldwide, help prevent and fight devastating disease outbreaks, and will save lives while saving millions of euros in healthcare and lost working hours. This has never been done before, and our consortium has the interdisciplinary research capacities to make it a reality.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.998.500 |
| Totale projectbegroting | € 2.998.500 |
Tijdlijn
| Startdatum | 1-7-2023 |
| Einddatum | 30-6-2027 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- IRIDEON SLpenvoerder
- AVIA-GIS NV
- UNIVERSITE CATHOLIQUE DE LOUVAIN
- INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- NAZKA MAPPS BVBA
- Agencia de Salut Publica de Barcelona
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Dynamic Spatio-Temporal Modulation of Light by Phononic ArchitecturesDynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements. | EIC Pathfinder | € 2.552.277 | 2022 | Details |
Emerging technologies for crystal-based gamma-ray light sourcesTECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology. | EIC Pathfinder | € 2.643.187 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures
Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.
Emerging technologies for crystal-based gamma-ray light sources
TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoesThis project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies. | ERC STG | € 1.500.000 | 2023 | Details |
The Multitudes of Mosquito Viruses and Their Impact on Arbovirus Disease EcologyThis project aims to explore the biology and ecology of mosquito-specific viruses to understand their interactions with arboviruses and mosquitoes, potentially improving arbovirus transmission control. | ERC STG | € 1.500.000 | 2025 | Details |
Mosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector controlMolecular Attraction aims to evaluate the efficacy and environmental impact of innovative mosquito-specific semiochemicals in sub-Saharan Africa to enhance vector control and reduce disease burden. | EIC Accelerator | € 2.500.000 | 2023 | Details |
The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and ZikaATLAS aims to develop the first broad-spectrum antiviral for flavivirus infections, conducting Phase I and IIa trials for dengue to attract pharmaceutical partnerships for commercialization. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Mosquito-virus matchmaking: Elucidating the biological basis of compatibility between viruses and mosquitoes
This project aims to utilize single-cell technology and gene editing to understand and manipulate the compatibility between viruses and mosquito vectors, enhancing disease control strategies.
The Multitudes of Mosquito Viruses and Their Impact on Arbovirus Disease Ecology
This project aims to explore the biology and ecology of mosquito-specific viruses to understand their interactions with arboviruses and mosquitoes, potentially improving arbovirus transmission control.
Mosquito-specific phagostimulants and pheromones for environment-friendly mosquito vector control
Molecular Attraction aims to evaluate the efficacy and environmental impact of innovative mosquito-specific semiochemicals in sub-Saharan Africa to enhance vector control and reduce disease burden.
The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and Zika
ATLAS aims to develop the first broad-spectrum antiviral for flavivirus infections, conducting Phase I and IIa trials for dengue to attract pharmaceutical partnerships for commercialization.